New study tracks meningitis vaccine safety in pregnancy
NCT ID NCT04843111
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study monitors the safety of the MenQuadfi vaccine when given to pregnant women or within 30 days before their last period. Researchers will track side effects in mothers and health outcomes in babies, including birth defects and complications. About 50 women in the U.S. will participate to help ensure the vaccine is safe during pregnancy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Pennsylvania Locations
RECRUITINGSwiftwater, Pennsylvania, 18370-0187, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.